University of Chicago
The purpose of this protocol is to study the efficacy of hiatal closure for early GERD disease. The study team hypothesizes that hiatal closure for early GERD disease is an efficacious treatment of GERD.
Gastro-Esophageal Reflux Disease (GERD) affects 60 million Americans involving an estimated 20 million Americans dependent on long term medication to control symptoms and progression of the disease. Although surgical hiatal hernia repair and creation of an anti-reflux valve can correct the underlying cause of GERD by repairing the anatomic defect and reestablishing the competency of the lower esophageal sphincter (LES), only 24,000 patients annually undergo surgery for GERD. However, with the advent of minimally invasive laparoscopic techniques to treat GERD, more patients at early phases of t…
Inclusion Criteria: * Age 18 - 50 years * Able to provide informed consent * BMI \<30 * Hiatal defect \<4cm on esophagram * pH testing requirement: pH \<4 for \>5.5% * Surgical candidate for hiatal closure only Exclusion Criteria: * Vulnerable subjects (children, prisoners, pregnant women) will be excluded.
Arctuva estimate
Verify or correct the compensation shown for this listing.